Sugar Editorial Picks
Apr 13, 2007 -
Since seasonal allergies are upon us, many of you may be reaching for allergy pills to get rid of your stuffy or runny nose. These meds do an excellent job of drying up your runny nose, but that's not the only thing getting dried out. Doctors tend to leave out this little tidbit of information: Allergy medicine causes vaginal dryness.
- 9 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Oral Contraception
- Implant Contraception
- Injected Contraception
- Intrauterine Devices (IUDs)...
- Spermicidal and Barrier Con...
- Natural Family Planning Met...
- Emergency Contraception
- Female Sterilization
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
First "No-Period" Birth Control Pill Approved
In May 2007, the Food and Drug Administration approved Lybrel, the first birth control pill that completely eliminates monthly menstrual periods. Lybrel contains low doses of the estrogen estradiol and the progestin levonorgestrol. The active pills are taken 365 days a year with no inactive pill breaks.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications of Depression...
- Diagnosis
- Treatment
- Antidepressants and Drug Tr...
- Psychotherapy
- Other Treatments
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the Food and Drug Administration (FDA) approved the atypical antipsychotic drug aripiprazole (Abilify) for treatment of major depression in adults. Aripiprazole is used for treatment of schizophrenia and bipolar disorder. For depression, it is used in combination with antidepressant drug therapy.
- 5 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Lifestyle or Psychological ...
- Physical Causes
- Prognosis
- Diagnosis
- Treatment
- Lifestyle Changes
- Medications
- Injections or Topical Treat...
- Other Treatments
- Natural Remedies
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
FDA Warns about Dietary Supplements
In 2006 and 2007, the FDA issued numerous warnings about “natural” dietary supplements promoted for erectile dysfunction and sexual enhancement. These products -- marketed under names such as “True Man,” “Energy Max,” “Rhino Max”-- contain illegal substances that can interact with prescription drugs and dangerously lower blood pressure. The interaction risks are greatest for men with diabetes, high blood pressure, high cholesterol, or heart disease who take prescription drugs that contain nitrates.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Outlook and Effects
- Diagnosis
- Treatment
- Treatment After The First S...
- Medications
- Surgery
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the Food and Drug Administration (FDA) approved levetiracetam (Keppra) for treatment of primary generalized tonic-clonic seizures in adults, and children ages 6 years and older, who have idiopathic generalized epilepsy. Levetiracetam was previously approved for partial-onset seizures and myoclonic seizures.
Carbamazepine and Genetic Testing
In 2007, the FDA recommended that patients of Asian ancestry get a genetic test prior to taking carbamazepine (Tegetrol, Equetro, Carbatrol).
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- The Autoimmune Disease Proc...
- Symptoms
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Drug Treatment
- Other Treatments
- Treating the Complications...
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Gender and Multiple Sclerosis (MS)
MS is increasingly affecting women, according to research presented at the 2007 annual conference of the American Academy of Neurology. Researchers found that in the 1940s, women were twice as likely as men to be diagnosed with MS. By 2000, women were about four times more likely than men to develop MS.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Prognosis
- Symptoms
- Prevention
- Diagnosis
- Treatment for Cervical Intr...
- Treatment for Cervical Canc...
- Treatment for Invasive Cerv...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Human Papilloma Virus (HPV) Prevalence
About 25% of women age 14 - 59 are infected with the human papilloma virus (HPV), indicates a 2007 study in the Journal of the American Medical Association (JAMA). HPV prevalence is highest (45%) among women age 20 - 24. HPV is the main cause of cervical cancer.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Lifestyle Changes
- Medications
- Conservative Surgery
- Hysterectomy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
Women with menstrual pain due to endometriosis have a new treatment option. In May 2007, the FDA approved Lybrel, a continuous-dose oral contraceptive that completely eliminates menstrual periods. Lybrel, which contains low doses of the estrogen estradiol and the progesterone levonorgestrol, is taken 365 days a year with active pills.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Levadopa (L-dopa)
- Other Medications
- Surgery
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2007, the FDA approved the first skin patch drug for treatment of Parkinson’s disease. Transdermal rotigotine (Neupro) is a dopamine agonist drug that may help improve symptoms of early-stage Parkinson’s disease. The patch is applied daily.
- Rivastigimine (Exelon), an Alzheimer’s disease drug, was approved in 2006 for treatment of mild-to-moderate dementia associated with Parkinson’s disease.
Drug Withdrawal
In 2007, the FDA withdrew the dopamine agonist pergolide (Permax) from the market due to safety concerns.
- 2 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Prognosis
- Causes
- Risk Factors
- Diagnosis
- Treatment Approaches
- Medications Used for Treatm...
- Prevention
- Medications Used for Preven...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Migraine Surveys
- About 17.1% of women and 5.6% of men suffer migraines, according to the 2007 American Migraine Prevalence and Prevention survey. Nearly a third of respondents reported 3 or more migraine attacks per month. Over half were severely impaired or needed bed rest during attacks.
- 1 Comment